Refresh

Aurobindo Pharma Ltd.

Price on BSE   23 Apr,15:49 LIVE
1,247.80
+59.70
(+5.02%)

© 2025 Rediff.com
  • Volume :
  • 84,170.00
  • Prev Close :
  • 1,188.10
  • Day's H/L (Rs.) :
  • 1,252.00 - 1,182.50
  • 52wk H/L (Rs.) :
  • 1,592.55 - 994.35
  • Mkt Cap (Rs. Cr) :
  • 72,472.23
Price on NSE   23 Apr,15:54 LIVE
1,246.80
+59.10
(+4.98%)

© 2025 Rediff.com
  • Volume :
  • 1,339,975.00
  • Prev Close :
  • 1,187.70
  • Day's H/L (Rs.) :
  • 1,253.00 - 1,182.80
  • 52wk H/L (Rs.) :
  • 1,592.00 - 1,010.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Indian Pharma Gets Relief from Trump's Tariffs
Rediff.com   04 Apr 2025
Report Card - Aurobindo Pharma Ltd.
PE Ratios
35.59
EPS (Rs.)
33.35
Sales (Rs. Cr)
2,916.63
Face Value (Rs.)
1
Net Profit Margin(%)
18.35
Last Bonus
1:1
Last Dividend(%)
150
Return on Average Equity
9.9

News for Aurobindo Pharma Ltd.

USFDA Issues Form...
USFDA Issues Form 483 to Aurobindo Pharma Plant
Aurobindo Pharma received a Form 483 with 11 observations from the USFDA for its Raleigh plant in North Carolina. The company plans to address the procedural observations.
Apr 11, 2025 14:54
Pharma Stocks...
Pharma Stocks Sink Amid US Tariff Threat
Indian pharma stocks plunged on Wednesday following reports that the US will soon announce tariffs on pharmaceutical imports. Blue Jet Healthcare, Marksans Pharma, Wockhardt, Glenmark...
Apr 09, 2025 17:55
Pharma Stocks...
Pharma Stocks Plunge on Trump Tariff Threat
Pharmaceutical stocks tumbled up to 10% after reports of Trump imposing tariffs on imports. Aurobindo, Laurus, Ipca, Lupin, Biocon, and Cipla were among the hardest hit.
Apr 04, 2025 12:03
Pharma Stocks...
Pharma Stocks Surge 14% on US Tariff Exemption: Gland, Aurobindo Lead
Indian pharmaceutical stocks soared after the US exempted drugs from reciprocal tariffs. Gland Pharma and Aurobindo Pharma led the rally, gaining over 14% and 9% respectively.
Apr 03, 2025 10:59
Aurobindo...
Aurobindo Terminates Pentavalent Vaccine Pact with Hilleman Labs
Aurobindo Pharma's subsidiary Auro Vaccines has terminated a license agreement with Singapore-based Hilleman Laboratories for a pentavalent vaccine candidate. The agreement, signed in September...
Mar 05, 2025 15:26

More News for Aurobindo Pharma Ltd. »

News for Pharmaceuticals and health care

PNB Launches...
PNB Launches 'Nirman 2025' Retail Loan Campaign
PNB announces 'PNB Nirman 2025', offering special benefits on home, car, and education loans until June 20, 2025. Explore exclusive offers and low interest rates.
Apr 23, 2025 20:21
RBI Eases Export...
RBI Eases Export Rules for UAE's Bharat Mart
Reserve Bank of India (RBI) relaxes norms for exports through Bharat Mart, a UAE-based marketplace, allowing Indian exporters to realize and repatriate full export value within nine months.
Apr 23, 2025 20:15
Synthetic Knitted Fabrics MIP Exemptions for EOUs, SEZs
India exempts advance authorization holders, EOUs, and SEZs from MIP on synthetic knitted fabrics. DGFT introduces new field in eBRC for services export data accuracy.
Apr 23, 2025 20:06
Dalmia Bharat Q4 Profit Up 37%, Revenue Down 5%
Dalmia Bharat's net profit surged 37.18% to Rs 439 crore in Q4 FY25, driven by cost efficiency measures. Revenue declined 5% due to lower sales volume and softening prices.
Apr 23, 2025 20:03
Nabard Invests in Agri-Fintech 24x7 Moneyworks for Rural Credit Digitization
Nabard acquires 10% stake in 24x7 Moneyworks, a leading agri-fintech firm, to boost rural credit digitization through its eKisanCredit platform.
Apr 23, 2025 19:58

More News »

Top News

PNB Launches 'Nirman 2025' Retail Loan Campaign
PNB announces 'PNB Nirman 2025', offering special benefits on home, car, and education loans until June 20, 2025. Explore exclusive offers and low interest rates.
Apr 23, 2025 20:21
RBI Eases Export Rules for UAE's Bharat Mart
Reserve Bank of India (RBI) relaxes norms for exports through Bharat Mart, a UAE-based marketplace, allowing Indian exporters to realize and repatriate full export value within nine months.
Apr 23, 2025 20:15
Tata Teleservices (Maharashtra) Loss Narrows in Q4
Tata Teleservices (Maharashtra) reports a narrowed loss of Rs 306.42 crore in the January-March quarter of FY 2024-25. Revenue declined by 5% to Rs 308.27 crore.
Apr 23, 2025 20:12
Synthetic Knitted Fabrics MIP Exemptions for EOUs, SEZs
India exempts advance authorization holders, EOUs, and SEZs from MIP on synthetic knitted fabrics. DGFT introduces new field in eBRC for services export data accuracy.
Apr 23, 2025 20:06
Dalmia Bharat Q4 Profit Up 37%, Revenue Down 5%
Dalmia Bharat's net profit surged 37.18% to Rs 439 crore in Q4 FY25, driven by cost efficiency measures. Revenue declined 5% due to lower sales volume and softening prices.
Apr 23, 2025 20:03

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com